Fusion Antibodies' Richard Jones presents his company to our Proactive audience.
The firm offers a range of antibody engineering services for all stages of therapeutic and diagnostic antibody development.
Established in 2001 as a spin out from Queen's University Belfast. The Company's mission is to enable pharmaceutical and diagnostic companies to develop innovative products in a timely and cost-effective manner for the benefit of the global healthcare industry.